Gemfibrozil and Simvastatin: Interaction Details
- Gemfibrozil
- Lopid
- Simvastatin
- FlolipidZocor
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Gemfibrozil and Simvastatin interaction:
Simvastatin
- Flolipid
- Zocor
What Happens When You Take Gemfibrozil With Simvastatin
What can happen when they are taken together (rated Contraindicated)
Increased exposure of simvastatin acid (active ) and an increased risk of or
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Because it raises the likelihood of myopathy and rhabdomyolysis, of simvastatin with gemfibrozil is .3 Gemfibrozil inhibits the , and giving it together with simvastatin has led to greater simvastatin exposure.1
When a small group of subjects received the two drugs concurrently over a short period, neither myopathy nor rhabdomyolysis developed, although creatine phosphokinase (CPK) levels rose transiently and without symptoms to as much as 2.5 times the upper limit of normal.4 Multiple case reports nonetheless describe myopathy in patients receiving simvastatin combined with gemfibrozil.9 The combination product ezetimibe/simvastatin is likewise contraindicated for use with gemfibrozil.2
The Gemfibrozil and Simvastatin Interaction, Explained
Taking gemfibrozil (Lopid) and simvastatin (Zocor) together is a combination that should be avoided. Gemfibrozil blocks one of the main ways your liver pulls simvastatin out of your blood. As a result, simvastatin can build up in your body, which raises the risk of muscle damage. In rare cases, this can become a serious condition called , which can harm the kidneys.
Watch for unexplained muscle pain, weakness, or tenderness, or dark, tea-colored urine. If you have been prescribed both, please talk with your pharmacist or doctor soon. They can work with you on a safer plan for managing your cholesterol.
. Gemfibrozil inhibits -mediated uptake of simvastatin acid (the active ), increasing systemic exposure () and the risk of and . This increases the effect of simvastatin.
- Evidence: Established. Increased simvastatin acid exposure has been demonstrated. Short-term produced transient, asymptomatic CPK elevations up to 2.5 times ULN, and multiple case reports document myopathy.
- Onset: Delayed.
- Management: Avoid concomitant use. Ezetimibe/simvastatin with gemfibrozil is also contraindicated. If the combination is found, contact the prescriber to select alternative lipid therapy. Assess for myalgia, weakness, elevated CK, and myoglobinuria.
See the 9 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Gemfibrozil and Simvastatin Interact
The likely mechanism
of -mediated simvastatin acid transport by gemfibrozil
How to Manage the Gemfibrozil and Simvastatin Interaction
These two medicines are not meant to be used together. This also applies to combination products that contain simvastatin, such as ezetimibe/simvastatin. Your care team will typically choose a different approach to managing your cholesterol or triglycerides instead of using both.
- Do not stop or change either medicine on your own. Contact your pharmacist or prescriber promptly so they can review your regimen.
- Tell them about any muscle pain, tenderness, or weakness, or dark urine. Seek care right away if these are severe.
- Make sure every prescriber and pharmacy you use knows all of your medications.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Gemfibrozil or Simvastatin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
7 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Role of gemfibrozil as an inhibitor of CYP2C8 and membrane transporters
When simvastatin was given together with gemfibrozil (an of the ), the of simvastatin acid (the active ) rose 2.9-fold.1
-
Report 2 · Study title
The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia
A 30-week outpatient study enrolled 19 adults with type III hyperlipoproteinemia who received simvastatin (20 mg daily or 40 mg daily) either alone or together with gemfibrozil (450 mg daily). Among the six patients given simvastatin 40 mg plus gemfibrozil 450 mg for eight weeks, none developed or .
Nonetheless, two of these patients had transient, asymptomatic rises in creatine phosphokinase (CPK) reaching a maximum of 2.5 times the upper limit normal. Relative to simvastatin 20 mg or 40 mg given alone, the combination produced additional reductions in plasma total cholesterol, very low density lipoprotein cholesterol, and triglycerides, although these differences did not reach statistical significance. The authors advised that combined fibrate and HMG CoA reductase therapy be limited to patients with severe hyperlipidemia whose response to monotherapy is inadequate.4
-
Report 3 · Study title
Long-term safety and efficacy of combination gemfibrozil and HMG-CoA reductase inhibitors for the treatment of mixed lipid disorders
A prospective study of 108 patients receiving simvastatin with gemfibrozil for mixed lipid abnormalities recorded a single episode of , which resolved after the combination therapy was discontinued.5
-
Report 4 · Study title
Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil
A 62-year-old patient with diabetes receiving several medications, among them simvastatin and gemfibrozil, developed signs of , including raised serum creatinine and CPK levels. After both drugs were stopped and intensive supportive care was provided, the patient's function and CPK level normalized.
The researchers additionally describe a 50-year-old woman with diabetes who was maintained on simvastatin and gemfibrozil for hyperlipidemia. Her simvastatin dose was titrated upward from 10 mg per day to 80 mg per day.
Three months into this regimen, she presented with fatigue, generalized myalgia and anuria, and was diagnosed with rhabdomyolysis accompanied by significant renal deficiency. Urine testing showed myoglobin, and her CPK level was 8280 mmol/L. Discontinuation of both drugs led to a gradual recovery of renal function to normal levels.6
-
Report 5 · Study title
Rhabdomyolysis associated with simvastatin-gemfibrozil therapy
A case report details a patient receiving gemfibrozil and simvastatin who required hospitalization three weeks later because of severe proximal muscle weakness, anorexia, and nausea. Serum CK, aldolase, BUN, creatinine, SGOT and SGPT levels were elevated at presentation.
Myoglobin was detected in the urine. Electromyography showed myositis and significant polyneuropathy affecting the lower limbs. Simvastatin and gemfibrozil were stopped, and following seven days of supportive care with hydration and prednisone, the patient's CK value and function returned to normal levels.7
-
Report 6 · Study title
Plasma concentrations od active simvastatin acid are increased by gemfibrozil
Gemfibrozil raises of simvastatin and of its active form, simvastatin acid. A two-phase, double-blind, randomized, crossover study in ten healthy volunteers was conducted to evaluate how gemfibrozil affects simvastatin .
Compared with placebo, gemfibrozil raised the mean total area under the plasma concentration-time curve () of simvastatin by 35% (p less than 0.01) and that of simvastatin acid by 185% (p less than 0.001). Gemfibrozil also prolonged the of simvastatin by 74% (p less than 0.05) and of simvastatin acid by 51% (p less than 0.01).
In addition, peak concentration of simvastatin acid rose by 112% (p less than 0.01). The authors propose that the greater risk of observed in patients on combination therapy may be pharmacokinetically based.8
-
Report 7 · Study title
Prescribing information: VYTORIN oral tablets, ezetimibe simvastatin oral tablets
In drug interaction studies, giving gemfibrozil 600 mg BID for 3 days with simvastatin 40 mg raised the of simvastatin and its active simvastatin acid by 1.35 and 2.85, and increased by 0.91 and 2.18, respectively.2
Gemfibrozil and Simvastatin: Common Questions
How serious is the Gemfibrozil and Simvastatin interaction?
It is rated . These should generally not be used together.
How is the Gemfibrozil and Simvastatin interaction managed?
These two medicines are not meant to be used together. This also applies to combination products that contain simvastatin, such as ezetimibe/simvastatin. Your care team will typically choose a different approach to managing your cholesterol or triglycerides instead of using both. Do not stop or change either medicine on your own. Contact your pharmacist or prescriber promptly so they can review yo… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How strong is the evidence for this interaction?
The evidence is graded "established". Well documented — supported by controlled studies or strong clinical data.
Ask About the Gemfibrozil and Simvastatin Interaction
Ask in your own words about taking Gemfibrozil and Simvastatin together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (9)
- Tornio A, Neuvonen PJ, Niemi M, et al: Role of gemfibrozil as an inhibitor of CYP2C8 and membrane transporters. Expert Opin Drug Metab Toxicol 2017; 13(1):83-95. PubMed
- Product Information: VYTORIN(R) oral tablets, ezetimibe simvastatin oral tablets. Organon LLC (per FDA), Jersey City, NJ, 2024. DailyMed
- Product Information: ZOCOR(R) oral tablets, simvastatin oral tablets. Organon & Co (per FDA), Jersey City, NJ, 2022. DailyMed
- Feussner G, Eichinger M, & Ziegler R: The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia. Clin Investig 1992; 70:1027-1035. PubMed
- Murdock DK, Murdock AK, Murdock RW, et al: Long-term safety and efficacy of combination gemfibrozil and HMG-CoA reductase inhibitors for the treatment of mixed lipid disorders. Am Heart J 1999; 138(1):151-155. PubMed
- Van Puijenbroek EP, Du Buf-Vereijken PW, Spooren PF, et al: Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil. J Internal Med 1996; 240:403-404. PubMed
- Tal A, Rajeshawari M, & Isley W: Rhabdomyolysis associated with simvastatin-gemfibrozil therapy. South Med J 1997; 90(5):546-7. PubMed
- Backman JT, Kyrklund C, Kivisto, et al: Plasma concentrations od active simvastatin acid are increased by gemfibrozil. Clin Pharmacol Ther 2000; 68:122-129.
- Van Puijenbroek EP, Du Buf-Vereijken PW, Spooren PF, et al: Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil. J Intern Med 1996; 240(6):403-4. PubMed
Other Serious Interactions of Gemfibrozil and Simvastatin
Also serious with Gemfibrozil
- DaprodustatContraindicated
- EzetimibeContraindicated
- ElagolixContraindicated
- RepaglinideContraindicated
Also serious with Simvastatin
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Gemfibrozil
- Activated CharcoalMajor
- WineMajor
- BeerMajor
- Siberian CockleburMajor
- Vitamin AModerate
- TurmericModerate
- Green TeaModerate
- AshwagandhaModerate
- + 51 more
With Simvastatin
- GrapefruitMajor
- St. John's WortMajor
- AppleMajor
- Activated CharcoalMajor
- WineMajor
- BeerMajor
- Siberian CockleburMajor
- Sweet OrangeMajor
- + 179 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together. This interaction.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data. This interaction.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks. This interaction.
- UnspecifiedThe timing of this interaction is not well characterized.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.